海角原创

This study is accepting patients at both 海角原创 and Rush Copley Medical Center. Please see contact information below to join the study at one location.

The PRISM Study is a research study conducted by faculty in the Departments of Family and Preventive Medicine and Internal Medicine at 海角原创 designed to understand how weight loss medications (also called obesity medications) are being used by patients seen in primary care clinics at Rush. Primary care clinics include those in Family Medicine and Internal Medicine. To learn more about the PRISM study, go to or call the study team at (312) 942-1282.

In order to participate you must meet the following criteria:

• Are an adult without diabetes who has been prescribed liraglutide, semaglutide, or tirzepatide or newer medication approved by the FDA for long-term use for obesity treatment by a primary care provider.

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.